The Enterprise Value as of December 2024 (TTM) for Lisata Therapeutics, Inc. (LSTA) is 6.65M

According to Lisata Therapeutics, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 6.65M. This represents a change of 138.43% compared to the average of 2.79M of the last 4 quarters.

Lisata Therapeutics, Inc. (LSTA) Historical Enterprise Value (quarterly & annually)

How has LSTA Enterprise Value performed in the past?

The mean historical Enterprise Value of Lisata Therapeutics, Inc. over the last ten years is 23.09M. The current 6.65M Enterprise Value has changed 2.78% with respect to the historical average. Over the past ten years (40 quarters), LSTA's Enterprise Value was at its highest in in the December 2019 quarter at 386.28M. The Enterprise Value was at its lowest in in the September 2023 quarter at -14842260.00.

Lisata Therapeutics, Inc. (LSTA) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Lisata Therapeutics, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Lisata Therapeutics, Inc. (LSTA) Average Enterprise Value

How has LSTA Enterprise Value performed in the past?

The current Enterprise Value of Lisata Therapeutics, Inc. (LSTA) is greater than its 3-year, greater than its 5-year, and less than than its 10-year historical averages

Lisata Therapeutics, Inc. (LSTA) Enterprise Value vs. Peers

How is LSTA’s Enterprise Value compared to its peers?

Lisata Therapeutics, Inc.’s Enterprise Value is greater than Lixte Biotechnology Holdings, Inc. (3.06M), greater than Histogen Inc. (-4487565.00), greater than Imunon, Inc. (2.77M), less than Kineta, Inc. (6.78M), less than Rezolute, Inc. (247.14M), greater than Cyteir Therapeutics, Inc. (-20511738.00), less than XOMA Corporation (296.56M), greater than Protagenic Therapeutics, Inc. (2.29M), less than Tempest Therapeutics, Inc. (33.01M), less than Pulmatrix, Inc. (11.36M), less than Onconova Therapeutics, Inc. (29.72M), less than Catalyst Biosciences, Inc. (1.01B), greater than Bio-Path Holdings, Inc. (3.94M), greater than Moleculin Biotech, Inc. (-3091562.00), less than Alpine Immune Sciences, Inc. (4.43B), less than AN2 Therapeutics, Inc. (7.13M), greater than Ampio Pharmaceuticals, Inc. (-3812048.00), less than Monte Rosa Therapeutics, Inc. (351.25M), less than Candel Therapeutics, Inc. (390.85M),

Build a custom stock screener for Lisata Therapeutics, Inc. (LSTA) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Lisata Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Lisata Therapeutics, Inc. (LSTA) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Lisata Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.